Option chain shows key data for Terumo's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Terumo.

Terumo (OTC:TRUMF) Stock, Option Chain

Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2024, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 36% of Terumo's revenue.

NARI

Analyst Color

Equities

News

Health Care

Price Target

Initiation

Analyst Ratings

Trading Ideas

General

TRUMF

TRUMY

Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth.

Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst

Biotech

BNTX

According to a lab study published in the New England Journal of Medicine, Pfizer Inc (NYSE: PFE)/BioNTech SE’s (NASDAQ: 

Comments

Terumo

Terumo (TRUMF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga